Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor.
about
Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2Airway epithelial epidermal growth factor receptor mediates hogbarn dust-induced cytokine release but not Ca2+ responseActivation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosisPathophysiological mechanisms of death resistance in colorectal carcinomaEicosanoid pathway in colorectal cancer: Recent updatesRole of redox signaling in neuroinflammation and neurodegenerative diseasesCyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during TherapyTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesProstaglandins and cancerPathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesisProstaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocationNovel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesDown-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerToll-like receptor-4 promotes the development of colitis-associated colorectal tumors.Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2.Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cellsSelective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanismsThe role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasiaRETRACTED: Novel management of oral cancer: a paradigm of predictive oncology.Aspirin and other NSAIDs as chemoprevention agents in melanomaPGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.Anti-scarring effects of butaprost on human subconjunctival Tenon's fibroblastsEicosanoids and cancerMyeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte functionEpidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.Amphiregulin promotes intestinal epithelial regeneration: roles of intestinal subepithelial myofibroblasts.Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation.Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potentialThe prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways.Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme.Immune biomarkers of anti-EGFR monoclonal antibody therapyInhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors.Fisetin inhibits UVB-induced cutaneous inflammation and activation of PI3K/AKT/NFκB signaling pathways in SKH-1 hairless mice.EGF receptor and COX-1/COX-2 enzyme proteins as related to corresponding mRNAs in human per-operative biopsies of colorectal cancer.15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.
P2860
Q21560840-AA4AA809-7025-45AC-8DF4-384F78EF8F2BQ23919646-510276E9-B254-4E68-9A7F-68385FC67B9EQ24314721-50995D9B-A3BA-4094-8667-DC71BF5863E2Q26778007-468C9269-B5B2-440E-81D5-FCCC6931F984Q26778011-D4C4FF54-E81E-4EB0-B5DB-9584B8F128C8Q27012569-E106C5E9-427A-4E3E-8006-2D6E70C89582Q28073252-56CA0BF0-2526-4E85-A7C7-18126D1D2A32Q28085631-F1999CFE-C26E-43B0-A259-C4BE2DF4AF1BQ28188827-05762FDA-8249-4951-BC42-C164756812EAQ28209990-3C1822D2-C412-4ED7-94E4-6EB784734C88Q28481397-33BE2ECE-88F2-4AA0-98F8-A43E406076A3Q28510195-B321959B-0A17-4F6C-A808-59ACEE4D30DCQ28550876-CAAFF5A9-B673-4132-BAD6-1EFF7D0E5EF4Q28575323-DECE4047-F5A3-434E-8D13-C9C863771A38Q28592082-3D87AA6B-611F-4435-AFDA-B334FE9F7611Q30481023-1A25F802-B8BD-42C2-9D63-3E1AD6A8462DQ30855607-2109AFC0-A3F0-46A2-AFB6-24981EB77646Q33389486-6F85189C-CFA3-4E5D-AF62-B6C0233C0D16Q33581564-8A25A3AE-27EE-4F34-A5C3-009D529D1915Q33634666-6C17FC40-ACAC-4167-95C2-04D5D277B849Q33723572-95C41525-CA4A-47F0-8456-A2755C7BE2E3Q33725012-B08A3267-82FD-4502-992A-F4FEC7D3BC41Q33761715-DDA48B70-99DD-495B-BBB0-69C316930C81Q33912443-595D6950-DB18-4A5E-A6B8-886332671C67Q33966203-E55530BF-AD69-4FA6-8DD8-98FFBD965A7EQ34009960-D9558048-1A58-4A21-A863-C2E4363C5F71Q34051967-358C750C-1A5F-41B8-88E2-71DB85E2439DQ34132456-651D1A5F-7CD4-4AED-960E-EC109290D377Q34279863-153C943D-8547-4307-9E0B-E1C2836ADAE8Q34324075-37867824-3E9F-437E-BE20-0D73CAE1874CQ34335080-215C62EF-D86F-4869-BB59-074D9107620DQ34338086-501248A6-AB87-4F16-9B80-5F2F2F568FE7Q34400793-0FE319BB-69A6-4FAA-AA08-1E83D3AB31B5Q34414026-774DC287-26AF-4EB7-A4A3-8C3F05154A86Q34637939-55996570-27F1-4B36-B0BE-C1D9491042B3Q34723594-DDF30200-3273-42AA-9DFC-902A7695D081Q34928661-40C724E0-1D5B-4DFC-9FDC-578EEB77D528Q34963960-1064044E-620C-47E1-AF77-5709244617DDQ35028757-3343345A-B54D-4A67-AEE1-8E5CE75EB2F9Q35033202-F840069D-F611-4776-8CE3-4C26245D2E72
P2860
Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prostaglandin E2 regulates cel ...... dermal growth factor receptor.
@en
Prostaglandin E2 regulates cel ...... dermal growth factor receptor.
@nl
type
label
Prostaglandin E2 regulates cel ...... dermal growth factor receptor.
@en
Prostaglandin E2 regulates cel ...... dermal growth factor receptor.
@nl
prefLabel
Prostaglandin E2 regulates cel ...... dermal growth factor receptor.
@en
Prostaglandin E2 regulates cel ...... dermal growth factor receptor.
@nl
P2093
P356
P1476
Prostaglandin E2 regulates cel ...... dermal growth factor receptor.
@en
P2093
Dingzhi Wang
F Gregory Buchanan
Francesca Bargiacchi
Raymond N DuBois
P304
35451-35457
P356
10.1074/JBC.M302474200
P407
P577
2003-06-24T00:00:00Z